Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 613831, 8 pages
http://dx.doi.org/10.1155/2015/613831
Research Article

Contrast-Enhanced Ultrasonography Features of Breast Malignancies with Different Sizes: Correlation with Prognostic Factors

1Department of Medical Ultrasound, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, China
2Ultrasound Research and Education Institute, Tongji University School of Medicine, Shanghai 200072, China
3Department of Pathology, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai 200072, China

Received 30 March 2015; Revised 1 December 2015; Accepted 14 December 2015

Academic Editor: Cristiana Corsi

Copyright © 2015 Li-Xia Zhao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Du, L. Wang, C.-F. Wan et al., “Differentiating benign from malignant solid breast lesions: combined utility of conventional ultrasound and contrast-enhanced ultrasound in comparison with magnetic resonance imaging,” European Journal of Radiology, vol. 81, no. 12, pp. 3890–3899, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Wan, J. Du, H. Fang, F. Li, and L. Wang, “Evaluation of breast lesions by contrast enhanced ultrasound: qualitative and quantitative analysis,” European Journal of Radiology, vol. 81, no. 4, pp. e444–e450, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Mishima, U. Toh, N. Iwakuma, M. Takenaka, M. Furukawa, and Y. Akagi, “Evaluation of contrast Sonazoid-enhanced ultrasonography for the detection of hepatic metastases in breast cancer,” Breast Cancer, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. C. F. Wan, J. Du, H. Fang, F. H. Li, J. S. Zhu, and Q. Liu, “Enhancement patterns and parameters of breast cancers at contrast-enhanced US: correlation with prognostic factors,” Radiology, vol. 262, no. 2, pp. 450–459, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. B. K. Szabó, A. Saracco, E. Tánczos et al., “Correlation of contrast-enhanced ultrasound kinetics with prognostic factors in invasive breast cancer,” European Radiology, vol. 23, no. 12, pp. 3228–3236, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Cao, G. E, E. Wang et al., “VEGF exerts an angiogenesis-independent function in cancer cells to promote their malignant progression,” Cancer Research, vol. 72, no. 16, pp. 3912–3918, 2012. View at Publisher · View at Google Scholar
  7. A. Fantozzi, D. C. Gruber, L. Pisarsky et al., “VEGF-mediated angiogenesis links EMT-induced cancer stemness to tumor initiation,” Cancer Research, vol. 74, no. 5, pp. 1566–1575, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Huber, T. Helbich, J. Kettenbach, W. Dock, I. Zuna, and S. Delorme, “Effects of a microbubble contrast agent on breast tumors: computer-assisted quantitative assessment with color Doppler US—early experience,” Radiology, vol. 208, no. 2, pp. 485–489, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. C. W. Elston and I. O. Ellis, “Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. C. W. Elston & I. O. Ellis. Histopathology 1991; 19; 403–410,” Histopathology, vol. 41, no. 3a, pp. 151–153, 2002. View at Publisher · View at Google Scholar
  10. M. Yi, L. Huo, K. B. Koenig et al., “Which threshold for ER positivity? A retrospective study based on 9639 patients,” Annals of Oncology, vol. 25, no. 5, pp. 1004–1011, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Iwamoto, D. Booser, V. Valero et al., “Estrogen receptor (ER) mRNA and ER-related gene expression in breast cancers that are 1% to 10% ER-positive by immunohistochemistry,” Journal of Clinical Oncology, vol. 30, no. 7, pp. 729–734, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Penault-Llorca, F. André, C. Sagan et al., “Ki67 expression and docetaxel efficacy in patients with estrogen receptor-positive breast cancer,” Journal of Clinical Oncology, vol. 27, no. 17, pp. 2809–2815, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. A. C. Wolff, M. E. H. Hammond, J. N. Schwartz et al., “American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer,” Journal of Clinical Oncology, vol. 25, no. 1, pp. 118–145, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. Y.-H. Zhou, F. Tan, K. R. Hess, and W. K. A. Yung, “The expression of PAX6, PTEN, vascular endothelial growth factor, and epidermal growth factor receptor in gliomas: relationship to tumor grade and survival,” Clinical Cancer Research, vol. 9, no. 9, pp. 3369–3375, 2003. View at Google Scholar · View at Scopus
  15. Q. Jin, K. Hemminki, K. Enquist et al., “Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis,” Clinical Cancer Research, vol. 11, no. 10, pp. 3647–3653, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. B. K. Linderholm, B. Lindh, L. Beckman et al., “Prognostic correlation of basic fibroblast growth factor and vascular endothelial growth factor in 1307 primary breast cancers,” Clinical Breast Cancer, vol. 4, no. 5, pp. 340–347, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. A. D. Wagner, C. Thomssen, J. Haerting, and S. Unverzagt, “Vascular-Endothelial-Growth-Factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancer,” Cochrane Database of Systematic Reviews, vol. 7, Article ID CD008941, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Cunha, L. Gano, G. R. Morais, T. Thiemann, and M. C. Oliveira, “Progesterone receptor targeting with radiolabelled steroids: an approach in predicting breast cancer response to therapy,” Journal of Steroid Biochemistry and Molecular Biology, vol. 137, pp. 223–241, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Liu, S. K. Chia, E. Mehl et al., “Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients,” Breast Cancer Research and Treatment, vol. 119, no. 1, pp. 53–61, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. A. M. Gown, “Current issues in ER and HER2 testing by IHC in breast cancer,” Modern Pathology, vol. 21, supplement 2, pp. S8–S15, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. M.-Y. C. Polley, S. C. Y. Leung, L. M. McShane et al., “An international ki67 reproducibility study,” Journal of the National Cancer Institute, vol. 105, no. 24, pp. 1897–1906, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Mori, H. Ota, S. Mugikura et al., “Luminal-type breast cancer: correlation of apparent diffusion coefficients with the Ki-67 labeling index,” Radiology, vol. 274, no. 1, pp. 66–73, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Arjonen, R. Kaukonen, E. Mattila et al., “Mutant p53-associated myosin-X upregulation promotes breast cancer invasion and metastasis,” The Journal of Clinical Investigation, vol. 124, no. 3, pp. 1069–1082, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Raja, S. Kale, D. Thorat et al., “Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis,” Oncogene, vol. 33, no. 16, pp. 2053–2064, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. D. J. Hicklin and L. M. Ellis, “Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis,” Journal of Clinical Oncology, vol. 23, no. 5, pp. 1011–1027, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Poellinger, S. El-Ghannam, S. Diekmann et al., “Correlation between enhancement characteristics of MR mammography and capillary density of breast lesions,” European Journal of Radiology, vol. 83, no. 12, pp. 2129–2136, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. H. L. Shin, N. Cho, J. K. Seung et al., “Correlation between high resolution dynamic MR features and prognostic factors in breast cancer,” Korean Journal of Radiology, vol. 9, no. 1, pp. 10–18, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. X.-L. Cao, W. Bao, S.-G. Zhu et al., “Contrast-enhanced ultrasound characteristics of breast cancer: correlation with prognostic factors,” Ultrasound in Medicine and Biology, vol. 40, no. 1, pp. 11–17, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. T. C. Putti, D. M. Abd El-Rehim, E. A. Rakha et al., “Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis,” Modern Pathology, vol. 18, no. 1, pp. 26–35, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Bzyl, M. Palmowski, A. Rix et al., “The high angiogenic activity in very early breast cancer enables reliable imaging with VEGFR2-targeted microbubbles (BR55),” European Radiology, vol. 23, no. 2, pp. 468–475, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Liu, Y. Jiang, Q. Dai, Q. Zhu, L. Wang, and J. Lu, “Peripheral enhancement of breast cancers on contrast-enhanced ultrasound: correlation with microvessel density and vascular endothelial growth factor expression,” Ultrasound in Medicine and Biology, vol. 40, no. 2, pp. 293–299, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Aitken and M. Osman, “Factors affecting nodal status in invasive breast cancer: a retrospective analysis of 623 patients,” Breast Journal, vol. 16, no. 3, pp. 271–278, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Liu, Y.-H. Gao, D.-D. Li, Y.-C. Gao, L.-M. Hou, and T. Xie, “Comparative study of contrast-enhanced ultrasound qualitative and quantitative analysis for identifying benign and malignant breast tumor lumps,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 19, pp. 8149–8153, 2014. View at Publisher · View at Google Scholar · View at Scopus